Sabra Health Care REIT, Inc.

For the period ended Jun 30, 2026. Filed Aug 3, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 3, 2026

SBRA$21.47+2.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Equity

Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, March 31, 2025	237,936,460	$2,379	$4,591,907	$(1,907,266)	$15,212	$2,702,232	$—	$2,702,232
Net income	—	—	—	65,542	—	65,542	—	65,542
Other comprehensive loss	—	—	—	—	(17,243)	(17,243)	—	(17,243)
Amortization of stock-based compensation	—	—	3,531	—	—	3,531	—	3,531
Common stock issuance, net	1,855,713	19	29,612	—	—	29,631	—	29,631
Common dividends ($0.30 per share)	—	—	—	(72,208)	—	(72,208)	—	(72,208)
Balance, June 30, 2025	239,792,173	$2,398	$4,625,050	$(1,913,932)	$(2,031)	$2,711,485	$—	$2,711,485
Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, March 31, 2026	252,190,095	$2,522	$4,832,664	$(2,049,843)	$691	$2,786,034	$1,880	$2,787,914
Net loss	—	—	—	(25,202)	—	(25,202)	(46)	(25,248)
Other comprehensive income	—	—	—	—	5,406	5,406	—	5,406
Contribution from noncontrolling interests	—	—	—	—	—	—	2	2
Distributions to noncontrolling interests	—	—	—	—	—	—	(119)	(119)
Amortization of stock-based compensation	—	—	4,969	—	—	4,969	—	4,969
Common stock issuance, net	3,272,661	33	56,020	—	—	56,053	—	56,053
Common dividends ($0.30 per share)	—	—	—	(76,537)	—	(76,537)	—	(76,537)
Balance, June 30, 2026	255,462,756	$2,555	$4,893,653	$(2,151,582)	$6,097	$2,750,723	$1,717	$2,752,440

CONSOLIDATED STATEMENTS OF EQUITY (CONTINUED)

Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, December 31, 2024	237,586,882	$2,376	$4,592,605	$(1,874,633)	$20,940	$2,741,288	$—	$2,741,288
Net income	—	—	—	105,846	—	105,846	—	105,846
Other comprehensive loss	—	—	—	—	(22,971)	(22,971)	—	(22,971)
Amortization of stock-based compensation	—	—	7,806	—	—	7,806	—	7,806
Common stock issuance, net	2,205,291	22	24,639	—	—	24,661	—	24,661
Common dividends ($0.60 per share)	—	—	—	(145,145)	—	(145,145)	—	(145,145)
Balance, June 30, 2025	239,792,173	$2,398	$4,625,050	$(1,913,932)	$(2,031)	$2,711,485	$—	$2,711,485
Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’Equity · Noncontrolling Interests · Total Equity
Shares · Amounts
Balance, December 31, 2025	251,697,456	$2,517	$4,836,270	$(2,013,375)	$(3,571)	$2,821,841	$1,947	$2,823,788
Net income (loss)	—	—	—	15,678	—	15,678	(113)	15,565
Other comprehensive income	—	—	—	—	9,668	9,668	—	9,668
Contribution from noncontrolling interests	—	—	—	—	—	—	2	2
Distributions to noncontrolling interests	—	—	—	—	—	—	(119)	(119)
Amortization of stock-based compensation	—	—	9,758	—	—	9,758	—	9,758
Common stock issuance, net	3,765,300	38	47,625	—	—	47,663	—	47,663
Common dividends ($0.60 per share)	—	—	—	(153,885)	—	(153,885)	—	(153,885)
Balance, June 30, 2026	255,462,756	$2,555	$4,893,653	$(2,151,582)	$6,097	$2,750,723	$1,717	$2,752,440

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.